Kamal Adawi's most recent trade in Exagen Inc was a trade of 9,297 Common Stock done at an average price of $1.9 . Disclosure was reported to the exchange on March 4, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Exagen Inc | Kamal Adawi | CFO and Corporate Secretary | Sale of securities on an exchange or to another person at price $ 1.91 per share. | 04 Mar 2024 | 9,297 | 247,236 (1%) | 0% | 1.9 | 17,747 | Common Stock |
| Exagen Inc | Kamal Adawi | CFO and Corporate Secretary | Sale of securities on an exchange or to another person at price $ 1.91 per share. | 04 Mar 2024 | 3,487 | 243,749 (1%) | 0% | 1.9 | 6,660 | Common Stock |
| Exagen Inc | Kamal Adawi | CFO and Corporate Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 75,000 | 256,533 (2%) | 0% | 0 | Common Stock | |
| Exagen Inc | Adawi Kamal | CFO and Corporate Secretary | Sale of securities on an exchange or to another person at price $ 1.95 per share. | 06 Feb 2024 | 6,738 | 181,533 (1%) | 0% | 1.9 | 13,133 | Common Stock |
| Exagen Inc | Kamal Adawi | CFO and Corporate Secretary | Sale of securities on an exchange or to another person at price $ 2.30 per share. | 02 Mar 2023 | 3,667 | 188,271 (1%) | 0% | 2.3 | 8,432 | Common Stock |
| Exagen Inc | Kamal Adawi | CFO and Corporate Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2023 | 100,000 | 191,938 (1%) | 0% | 0 | Common Stock | |
| Exagen Inc | Kamal Adawi | CFO and Corporate Secretary | Sale of securities on an exchange or to another person at price $ 2.69 per share. | 08 Feb 2023 | 5,821 | 91,938 (0%) | 0% | 2.7 | 15,671 | Common Stock |
| Exagen Inc | Kamal Adawi | CFO and Corporate Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.12 per share. | 01 Mar 2022 | 3,241 | 97,759 (0%) | 0% | 7.1 | 23,076 | Common Stock |
| Exagen Inc | Kamal Adawi | CFO and Corporate Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 63,500 | 101,000 (0%) | 0% | 0 | Common Stock | |
| Exagen Inc | Kamal Adawi | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 37,500 | 37,500 (0%) | 0% | 0 | Common Stock | |
| Exagen Inc | Kamal Adawi | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 12,500 | 12,500 | - | - | Stock Option(right to buy) |